Causality, Impartiality and Evidence-Based Policy

History, Philosophy and Theory of the Life Sciences

Volumn 3, Issue , 2013, Pages 207-224

  Teira, David ^a   Reiss, Julian ^b  

^a UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

^b DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Causal Claim; Expert Judgement; External Validity; Mechanical Objectivity; Regulatory Decision

Indexed keywords

EID: 85078418040     PISSN: 22111948     EISSN: 22111956     Source Type: Book Series    
DOI: 10.1007/978-94-007-2454-9_11     Document Type: Chapter

References (34)

1. Akerlof, George. 1970. The market for ‘Lemons’: Quality uncertainty and the market mechanism. Quarterly Journal of Economics 84(3): 488–500.
2. Banerjee, Abhijit V., and Esther Duflo. 2009. The experimental approach to development economics. Annual Review of Economics 1(1): 151–178.
3. Bolton, Gary E., Jordi Brandts, and Axel Ockenfels. 2005. Fair procedures: Evidence from games involving lotteries. The Economic Journal 115(506): 1054–1076.
4. Carnevale, Anthony Patrick, Stephen J. Rose, and Century Foundation. 2003. Socioeconomic status, race/ethnicity, and selective admissions. http://www.tcf.org/Publications/White% 5FPapers/carnevale%5Frose.pdf. Accessed 15 Jan 2012.
5. Carpenter, Daniel P. 2010. Reputation and power: Organizational image and pharmaceutical regulation at the FDA. Princeton: Princeton University Press.
6. Carpenter, Daniel, and Colin Moore. 2007. Robust action and the strategic use of ambiguity in a bureaucratic cohort: FDA scientists and the investigational new drug regulations of 1963. In Formative acts, ed. Stephen Skowronek and Matthew Glassman, 340–362. Philadelphia: University of Pennsylvania Press.
7. Cartwright, Nancy. 2007. Are RCTs the gold standard? BioSocieties 2(1): 11–20.
8. Cartwright, Nancy, and Eileen Munro. 2010. The limitations of randomized controlled trials in predicting effectiveness. Journal of Evaluation in Clinical Practice 16(2): 260–266.
9. Deaton, Angus. 2010. Instruments, randomization, and learning about development. Journal of Economic Literature 48: 424–455.
10. Duflo, Esther. 2010. La politique de l’autonomie, Lutter contre la pauvreté, vol. 2. Paris: Seuil.
11. Duflo, Esther, and Michael Kremer. 2005. Use of randomization in the evaluation of development effectiveness. In Evaluating development effectiveness, World Bank Series on Evaluation and Development, vol. 7, ed. George Keith George, Osvaldo N. Feinstein, and Gregory K. Ingram, 205–232. New Brunswick/London: Transaction.
12. Duflo, Esther, and Rema Hanna. 2006. Monitoring works: Getting teachers to come to school: C.E. P.R. discussion papers, CEPR discussion papers: 5426. London
13. Duflo, Esther, Rachel Glennerster, and Michael Kremer. 2007. Using randomization in development economics research: A toolkit: C.E.P.R. discussion papers, CEPR discussion papers: 6059. London
14. Epstein, Steven. 1996. Impure science. Aids and the politics of knowledge. Berkeley: University of California Press.
15. Featherstone, Katie, and Jenny L. Donovan. 2002. “Why don’t they just tell me straight, why allocate it?” The struggle to make sense of participating in a randomised controlled trial. Social Science & Medicine 55(5): 709–719.
16. Hacking, Ian. 1988. Telepathy: Origins of randomization in experimental design. Isis 79(3): 427–451.
17. Heckman, James. 1992. Randomization and social policy evaluation. In Evaluating welfare and training programs, ed. F. Manski and Garfinkel Irwin, 201–230. Cambridge/London: Harvard University Press.
18. Imbens, G. 2010. Better LATE than nothing: Some comments on Deaton (2009) and Heckman and Urzua (2009). Journal of Economic Literature 48: 399–423.
19. Lasagna, L. 1959. Gripesmanship: A positive approach. Journal of Chronic Diseases 10: 459–468.
20. Macklin, Ruth. 2004. Double standards in medical research in developing countries, Cambridge Law, Medicine, and Ethics, vol. 2. Cambridge/New York: Cambridge University Press.
21. Marks, Harry M. 1997. The progress of experiment. Science and therapeutic reform in the United States, 1900–1990. New York: Cambridge University Press.
22. Marks, Harry M. 2000. Trust and mistrust in the marketplace: Statistics and clinical research, 1945–1960. History of Science 38: 343–355.
23. Orr, Larry L. 1999. Social experiments: Evaluating public programs with experimental methods. Thousand Oaks: Sage.
24. Petryna, Adriana. 2009. When experiments travel: Clinical trials and the global search for human subjects. Princeton: Princeton University Press.
25. Porter, Theodore M. 1995. Trust in numbers: The pursuit of objectivity in science and public life. Princeton: Princeton University Press.
26. Pritchett, Lant. 2002. It pays to be ignorant: A simple political economy of rigorous program evaluation. Journal of Policy Reform 5(4): 251–269.
27. Sackett, David, William Rosenberg, Muir Gray, Brian Haynes, and Scott Richardson. 1996. Evidence-based medicine: What it is and what it isn’t. British Medical Journal 312: 71–72.
28. Stone, Peter. 2007. Why lotteries are just? The Journal of Political Philosophy 15(3): 276–295.
29. Teira, D. 2011a. Frequentist versus Bayesian clinical trials. In Philosophy of medicine, ed. Fred Gifford, 255–297. Amsterdam: Elsevier.
30. Teira, D. 2011b. Impartiality in clinical trials. London: University College London.
31. Urbach, Peter. 1985. Randomization and the design of experiments. Philosophy of Science 52(2): 256–273.
32. Wilson, Charles. 2008. Adverse selection. In The New Palgrave dictionary of economics, 2nd ed. Steven N. Durlauf and Lawrence E. Blume. London: Palgrave Macmillan.
33. Worrall, John. 2002. What evidence in evidence-based medicine? Philosophy of Science 69(3 Supplement): S316–S330.
34. Worrall, John. 2007. Why there’s no cause to randomize. The British Journal for the Philosophy of Science 58(3): 451–488.